Received Nov 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB072A | — |
gave the menveo, but only gave the liquid conjugate; gave the menveo, but only gave the liquid conjugate; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 21-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB072A, expiry date 30-APR-2026) for prophylaxis. On 15-OCT-2025, the patient received Menveo. On 15-OCT-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: gave the menveo, but only gave the liquid conjugate) and inappropriate dose of vaccine administered (Verbatim: gave the menveo, but only gave the liquid conjugate). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 16-OCT-2025 The Registered Nurse had reported that vaccines had been administered at the clinic, including Menveo and a two-part conjugate vaccine. One of the nurses had given Menveo the previous afternoon but had only administered the liquid conjugate component.